Present results of the TACTIVE-N trial, a Phase 2 clinical trial of neoadjuvant vepdegestrant, in a mini oral session at European Society for Medical Oncology 2025 Congress (ClinicalTrials.gov ...

Trump administration terminates 22 mRNA vaccine contracts, shifting focus to safer alternatives, sparking controversy and ...

AI research is central to many of the deals. In April, French pharmaceutical giant Sanofi announced a $1.7 billion agreement ...

The Trump administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines despite safety ...

US President Donald Trump's administration has announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

President Donald Trump’s administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like COVID-19 and the ...

Palantir Technologies reported after the market closed yesterday and had another blowout quarter. Berkshire Hathaway was a ...

Leading CDMO Company for Pharmaceutical Solutions Asymchem has announced a significant expansion of its flow chemistry capabilities at its ...

The firm will continue developing Lava's two partnered bispecific gamma delta T-cell engager programs with Pfizer and Johnson & Johnson.

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million-pound battle against US rival Moderna over the Covid-19 vaccine.

Top women tech leaders shaping innovation in 2025, visionary women in tech driving inclusion, AI, biotech, and leadership excellence.